Literature DB >> 34208555

Impact of Planning Method (Conventional versus Virtual) on Time to Therapy Initiation and Resection Margins: A Retrospective Analysis of 104 Immediate Jaw Reconstructions.

Michael Knitschke1, Christina Bäcker1, Daniel Schmermund1, Sebastian Böttger1, Philipp Streckbein1, Hans-Peter Howaldt1, Sameh Attia1.   

Abstract

Virtual surgical planning (VSP) and patient-specific implants are currently increasing for immediate jaw reconstruction after ablative oncologic surgery. This technique contributes to more accurate and efficient preoperative planning and shorter operation time. The present retrospective, single-center study analyzes the influence of time delay caused by VSP vs. conventional (non-VSP) reconstruction planning on the soft and hard tissue resection margins for necessary oncologic safety. A total number of 104 cases of immediate jaw reconstruction with free fibula flap are included in the present study. The selected method of reconstruction (conventionally, non-VSP: n = 63; digitally, VSP: n = 41) are analyzed in detail. The study reveals a statistically significant (p = 0.008) prolonged time to therapy initiation with a median of 42 days when the VSP method compared with non-VSP (31.0 days) is used. VSP did not significantly affect bony or soft tissue resection margin status. Apart from this observation, no significant differences concerning local tumor recurrence, lymph node, and distant metastases rates are found according to the reconstruction method, and affect soft or bone tissue resection margins. Thus, we conclude that VSP for immediate jaw reconstruction is safe for oncological purposes.

Entities:  

Keywords:  fibula free flap; head and neck tumor; oral cancer; virtual surgical planning

Year:  2021        PMID: 34208555     DOI: 10.3390/cancers13123013

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

1.  [Application of personalized guide plate combined with real-time navigation in repairing mandibular defect using fibula muscle flap].

Authors:  Tingyi Gao; Dong Wang; Mo Chen; Zhaojun Zhan; Xiao Peng; Kai Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-06-15

2.  Osseous Union after Mandible Reconstruction with Fibula Free Flap Using Manually Bent Plates vs. Patient-Specific Implants: A Retrospective Analysis of 89 Patients.

Authors:  Michael Knitschke; Sophia Sonnabend; Fritz Christian Roller; Jörn Pons-Kühnemann; Daniel Schmermund; Sameh Attia; Philipp Streckbein; Hans-Peter Howaldt; Sebastian Böttger
Journal:  Curr Oncol       Date:  2022-05-06       Impact factor: 3.109

3.  Surgical Margins After Computer-Assisted Mandibular Reconstruction: A Retrospective Study.

Authors:  Erika Crosetti; Giovanni Succo; Bruno Battiston; Federica D'Addabbo; Martina Tascone; Elena Maldi; Ilaria Bertotto; Mattia Berrone
Journal:  Front Oral Health       Date:  2022-01-13

4.  Impact of Periosteal Branches and Septo-Cutaneous Perforators on Free Fibula Flap Outcome: A Retrospective Analysis of Computed Tomography Angiography Scans in Virtual Surgical Planning.

Authors:  Michael Knitschke; Anna Katrin Baumgart; Christina Bäcker; Christian Adelung; Fritz Roller; Daniel Schmermund; Sebastian Böttger; Philipp Streckbein; Hans-Peter Howaldt; Sameh Attia
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

5.  Clinical Outcomes and Cost Analysis of Fibula Free Flaps: A Retrospective Comparison of CAD/CAM versus Conventional Technique.

Authors:  Juan Pablo Rodríguez-Arias; Blanca Tapia; Marta María Pampín; Maria José Morán; Javier Gonzalez; Maria Barajas; Jose Luis Del Castillo; Carlos Navarro Cuéllar; Jose Luis Cebrian
Journal:  J Pers Med       Date:  2022-06-07

6.  Adherence to Computer-Assisted Surgical Planning in 136 Maxillofacial Reconstructions.

Authors:  Hongyang Ma; Sohaib Shujaat; Jeroen Van Dessel; Yi Sun; Michel Bila; Jan Vranckx; Constantinus Politis; Reinhilde Jacobs
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.